Rendering of Lilly's forthcoming manufacturing site in Alzey, Germany (Credit: Eli Lilly)

November 17, 2023 10:29 AM EST

Lilly invests $2.5B in new German site to boost tirzepatide supply, $100M for local biotechs

Anna Brown

News Reporter

Kyle LaHucik

Senior Reporter

Eli Lilly is set to build a new $2.5 billion facility in Germany to increase manufacturing capacity for its blockbuster diabetes and obesity drugs, and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Lilly invests $2.5B in new German site to boost tirzepatide supply, $100M for local biotechs

Anna Brown

News Reporter

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Among pharma CEOs, the IRA now and the IRA later get very different reactions

Bristol Myers restarts radiopharmaceutical Phase 3 trial, but delays readout by one year

Updated: With cost-cutting underway, Bristol Myers raises guidance, touts Phase 3 win and scraps another

Andrew Left, short seller who campaigned against Valeant, is accused of fraud by SEC

European drug regulator rejects Alzheimer's drug Leqembi, citing safety concerns

Critical Junctures in Gene Therapy Clinical Material Manufacturing: Where Do I Start? And Will It Work?

Lil­ly in­vests $2.5B in new Ger­man site to boost tirzepatide sup­ply, $100M for lo­cal biotechs

News Reporter

Senior Reporter

Sign up to read this article for free.

Lilly invests $2.5B in new German site to boost tirzepatide supply, $100M for local biotechs